CITCO inhibits growth and expansion of brain tumour stem cells (BTSCs) and has an EC50 of 49 nM over pregnane X receptor (PXR), and no activity on other nuclear receptors. CITCO is an imidazothiazole derivative and it also is a selective Constitutive androstane receptor (CAR) agonist.
Molekulargewicht:
436.74
Reinheit:
99.24%
CAS Nummer:
[338404-52-7]
Formel:
C19H12Cl3N3OS
Target-Kategorie:
Apoptosis
T14973
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten